news releases

June 28, 2010 — Burcon is pleased to report on the latest business activities with respect to the commercialization of its CLARISOY® soy protein isolate.

April 26, 2010 — Burcon wishes to recognize Burcon director Dr. D. Lorne Tyrrell, who has been appointed as the inaugural director of the new Li Ka Shing Institute of Virology in Canada.

April 20, 2010 — Burcon or the “Corporation”) is pleased to announce the appointment of Mr. Alan Chan to its board of directors.

April 8, 2010 — Burcon announces today that the Division of Biotechnology and GRAS Notice Review of the Center for Food Safety and Applied Nutrition of the Food and Drug Administration (the “FDA”) has formally acknowledged receipt of Burcon’s GRAS notification.

February 4, 2010 — Burcon is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions.

January 20, 2010 — Burcon is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering processes for reducing phytic acid in the production of protein isolates from oilseed meals.

January 19, 2010 — Burcon is pleased to announce today that a formal notification in accordance with the U.S. Food & Drug Administration (“FDA”) proposed regulation 62FR 18938 has been filed...

December 15, 2009 — Burcon is pleased to announce today that it has received notices of allowance from the United States Patent and Trademark Office for two separate patent applications.

December 1, 2009 — Burcon is pleased to announce the appointment of Dr. D. Lorne Tyrrell to its board of directors.

November 3, 2009 — Burcon announced today the publication of a peerreviewed manuscript describing a toxicology study of Supertein™ canola protein isolate.